PharmExec14h
Rybelsus Found to Significantly Reduce Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes, Cardiovascular Disease
In the SOUL trial, Rybelsus produced a 14% risk reduction of major adverse cardiovascular events in patients with type 2 ...
PharmExec23h
Eli Lilly Adds Alzheimer’s Care to Digital Health Platform Services
LillyDirect will help provide services to millions of patients who have yet to be formally diagnosed with the disease.
PharmExec23h
Balancing Cost-Efficiency with the Need for Domestic Manufacturing
Marcel Botha, CEO of 10XBeta, discusses finding a balance between the need for cost-efficiency and the need to build domestic manufacturing capacity for essential medical devices.